Serum Institute’s Covovax will be available on CoWIN as a heterologous booster dose.
According to a tweet by Adar Poonawalla, CEO and owner of Serum Institute, the vaccine is “now available on the CoWIN app.”
Covovax, developed by the Serum Institute in partnership with the US-based Novavax, is a recombinant spike protein nanoparticle vaccine. The vaccine is administered intramuscularly in two doses, with SII recommending a gap of three weeks between the jabs.
“As COVID cases have been rising again with Omicron XBB & its variants, it can be severe for the elderly. I’d suggest for the elderly, mask up and take the Covovax booster which is now available on the COWIN app. It is excellent against all variants & is approved in the US & Europe,” he wrote on Twitter.